Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Other Operating Expenses (2025)

CG Oncology's Other Operating Expenses history spans 1 years, with the latest figure at $3.1 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses changed N/A year-over-year to $3.1 million; the TTM value through Dec 2025 reached $4.6 million, changed N/A, while the annual FY2025 figure was $4.6 million, N/A changed from the prior year.
  • Other Operating Expenses reached $3.1 million in Q4 2025 per CGON's latest filing, up from $1.6 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $3.1 million in Q4 2025 to a low of $1.6 million in Q3 2025.